- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: GW642444 (Vilanterol)
Total 152 results
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Romania, Russian Federation, Ukraine, Germany, Hungary, Bulgaria
-
GlaxoSmithKlineQ2 Solutions; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel...Completed
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Argentina, Japan, Russian Federation, Spain, Germany, Mexico, Romania, Korea, Republic of, Poland, Italy, France
-
GlaxoSmithKlineCompletedAsthmaUnited States, Germany, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveChina
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveFrance, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Poland, Romania, Russian Federation, Ukraine, Bulgaria, Estonia, Mexico, Korea, Republic of, Slovakia, Greece, China, Italy, Hungary, Czechia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Small Intestine Cancer | Brain and Central Nervous System Tumors | Lymphoproliferative DisorderUnited States, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, China, Philippines, Korea, Republic of
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Korea, Republic of, Romania, Russian Federation, Spain, Netherlands, Mexico, Brazil, Chile, Czechia
-
GlaxoSmithKlineCompletedAsthmaAustralia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Germany, Japan, Poland, Romania, Russian Federation, Mexico, Ukraine, Australia, Philippines
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Morten Hostrup, PhDRecruitingExercise PerformanceDenmark
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedAsthmaGermany, Ukraine, United States, Peru, Poland
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineWithdrawnPulmonary Disease, Chronic ObstructiveCanada, Germany
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Russian Federation, Spain, Bulgaria, Canada, Hungary, Argentina
-
GlaxoSmithKlineCompletedAsthmaUnited Kingdom, Germany, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Ukraine, United States, Estonia, South Africa, Sweden, Norway, Russian Federation, Korea, Republic of
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Korea, Republic of, Czech Republic
-
University of VirginiaRecruitingChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, Thailand, China, Philippines, Korea, Republic of
-
GlaxoSmithKlineWithdrawn
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Canada, Argentina, Australia, Japan, Korea, Republic of, Taiwan
-
Mundipharma Research LimitedCompletedAsthmaUnited Kingdom, Sweden, Australia, New Zealand, Slovakia
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, Netherlands, Czechia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada, Germany, Romania, Poland, Czechia
-
Erasmus Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Stichting...TerminatedInvasive AspergillosisBelgium, Netherlands
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseGermany
-
University of DundeeBoehringer Ingelheim; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom